Pharmafile Logo

WTO

- PMLiVE

EU files WTO dispute with Turkey over pharma laws

Country breaks WTO obligations

- PMLiVE

Market access improvements in Turkey

With 78 million inhabitants, a universal public health insurance scheme, regulations largely harmonised with EU rules and a growing economy, Turkey - the largest market in the Middle East, North...

Turkey: Identifying the Growth Drivers

Published in eye for pharma 3 April by Marc Yates

Research Partnership

- PMLiVE

Eurocom Healthcare Comms expands to Turkey

Ixir Healthcare Communications joins alliance

- PMLiVE

Takeda grows in Turkey with Neutec subsidiary acquisition

Will acquire Toplam Kalite for up to 300m Turkish lira

- PMLiVE

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Exploring MINT: Part 4 – Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in...

Research Partnership

Turkey’s pharma market is ripe for profitability

But will the highly efficient market be hindered by the government price referencing system?

- PMLiVE

Turkey aims to become ‘global player’ in biopharma

Government pledges to boost country’s support for medicines access and R&D

ClinTec International expands into Turkey

CRO says new office will bolster its presence in the Middle East and North Africa

- PMLiVE

Interview: Giovanni Recordati

The chairman and CEO of Recordati tells Linda Banks his plans for company expansion

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links